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First results of clampless distal anastomosis in
peripheral vascular bypass with LeGoo, a
thermoreversible polymer
Benjamin Kretz, MD, Eric Steinmetz, PhD, Roger Brenot, PhD, and Olivier Bouchot, MD, Dijon, France
Background:We report our initial experience with LeGoo (Pluromed Inc, Woburn, Mass), a temporary thermoreversible
occlusive gel, in peripheral vascular revascularization.
Methods: Between 2007 and 2010, LeGoo was used to occlude target vessels during bypass surgery in 14 patients who
required infrainguinal revascularization.
Results: Proximal occlusion of the target vessel was obtained with a mean quantity of 0.25 mL of LeGoo. Distal occlusion
of the vessel was obtained with a mean quantity of 0.28 mL. One injection of LeGoo was sufficient to prevent
backbleeding in 11 of 14 patients. The mean occlusion time was 13.4  3.3 minutes. An injection of saline through the
graft or better directly into the arteries was used to dissolve the gel. For our first case, a Fogarty catheter was used to
remove residual gel from the anterior tibial artery.
Conclusions: LeGoo gel can be used to stop blood flow in small-bore arteries in the lower limbs to allow anastomoses to
be performed. (J Vasc Surg 2012;55:1821-5.)
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tCreating distal anastomoses in peripheral vascular by-
pass surgery requires clamping of the target vessel. Ideally,
clamping should allow the surgeon to work in a blood-free
operating field, without damaging the arterial wall and
without reducing the surgeon’s visual field.
External mechanical occlusion is generally achieved by
using vascular clamps, and arterial occlusion is generally
obtained, but sometimes at the price of irreversible damage
to the vascular wall.1,2 Compression of the limb using
tourniquets, with or without an Esmarch bandage to empty
venous blood from the limb, may help prevent direct vessel
trauma.3-5 The drawbacks of these techniques include (1)
adequate occlusion is not always achieved, (2) total occlu-
sion of the arterial network of the limb below the tourni-
quet, which can aggravate the ischemia by occluding col-
lateral supply, (3) injury to nerves, muscle, and skin, and (4)
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doi:10.1016/j.jvs.2011.11.103nduced spasm of the distal vessel.6 Use of the Esmarch
andage may also lead to embolism and skin trauma.
Internal vascular occlusion is achieved by using a balloon
atheter that is positioned in the arterial lumen and kept
nflated. This solution is useful because it precludes the risks
ssociated with lesions due to clamping. It does, however,
ake the intervention more complex for the surgeon.
LeGoo (Pluromed Inc,Woburn,Mass) is a P407 thermo-
ensitive poloxamer polymer that has shown its efficacy in
mall-vessel occlusion in preclinical experiments7-9 and more
ecently in humans for off-pump coronary artery revascular-
zation.10 It has been used for20 years, in different contexts,
ncluding transdermal applications and collyrium. The only
emonstrated toxicity is hypercholesterolemia for a dose of
ore than 2000 times that used for vascular occlusion.
LeGoo is a viscous liquid at room temperature that
mmediately solidifies when it is warmed to body tempera-
ure.9 Consequently, when it is injected into a blood vessel
t body temperature, the viscous liquid is instantaneously
ransformed into an occlusive plug that marries the con-
ours of a lumen, even when the lumen is distorted by
rterial disease. The plug maintains the cylindrical shape of
he target vessel, making it easier to insert sutures precisely,
nd can be pierced easily with a surgical needle.
The LeGoo plug dissolves spontaneously after 10 to 20
inutes in situ or can be dissolved at will by injecting cold
aline into the vessel or by using an instrument to disrupt
he plug. Once dissolved, LeGoo cannot form a new plug
ecause the concentration is too low, and it is excreted
1821
c
r
t
c
v
g
w
c
a
d
I
L
t
v
n
w
i
long
JOURNAL OF VASCULAR SURGERY
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neously before completion of the anastomosis, additional
injections can reconstitute the occlusion (Fig 1, A).
Experimental studies have analyzed the thermorevers-
ible proprieties of Poloxamer P407 and shown that it is
impossible for the solution to form a gel when the concen-
tration is below 12%.7-9 Preclinical experiments showed
that LeGoo is nontoxic. The plug dissolves from its micellar
form into unimeric molecules.9 We report our initial expe-
rience with LeGoo in peripheral revascularization surgery.
METHODS
Between 2007 and 2010, LeGoo was used in 14 pa-
tients (9 men, 5 women) with peripheral vascular disease
(PVD) by one surgeon (O.B.) at Le Bocage Hospital,
Dijon, France. During the same period, 102 revasculariza-
tions with distal bypasses using conventional clamping were
performed. The standardmethod used in our department is
a vascular clamp placed on a noncalcified area. A comple-
tion angiogram is systematically done at the end of the
Fig 1. Use of LeGoo. A, The surgeon creates an arteri
cannula. LeGoo dissolves slowly when in contact with
Cannulas with outer diameters of from 1.0 mm  4 cmprocedure. (The inclusion criteria were symptomatic patients, ac-
ording to Fontaine stages, with infrainguinal lesions that
equired distal bypasses. LeGoo was used when calcifica-
ions of the target vessel foreshadowed the difficulties of
lamping. Bypasses were done with the great saphenous
ein, when available, or with a Dacron prosthesis.
Surgical procedures. Surgery was performed under
eneral anesthesia. Heparin (50 IU/kg of body weight),
as administered once the surgical approaches had been
ompleted. A 4 mm arteriotomy was made in the target
rtery. A specially designed catheter of the appropriate
iameter and length, with a soft olive-shaped tip (Pluromed
nc Fig 1, B) and attached to a syringe prefilled with
eGoo, was inserted through the arteriotomy and pushed
o a position 1.5 to 2 cm proximal to the arteriotomy. The
iscous liquid LeGoo was injected by hand while the can-
ula was slowly withdrawn. To stop back-bleeding, LeGoo
as injected distally in a manner similar to the proximal
njection.
Once the operative field was bloodless, the conduit
y and injects LeGoo retrograde while withdrawing the
d. LeGoo is fully dissolved with ice or cold saline. B,
to 4.0 mm  8 cm long.otom
blooprosthesis or great saphenous vein) was anastomosed to
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sutures. If the LeGoo plug dissolved before completion of
the anastomosis and bleeding into the surgical field re-
sumed, additional LeGoo was injected to reconstitute the
plug and re-establish a bloodless field. When the suture line
was completed and before snugging the continuous suture,
the gel plug was allowed to dissolve spontaneously or was
dissolved by injecting cold saline into the artery. When
blood flow through the anastomosis was strong, the con-
tinuous suture was tightened and tied.
The quality of the hemostasis was defined as grade 1, no
bleeding; grade 2, minimal bleeding, but the anastomosis
could be performed without additional aid; grade 3, mod-
erate bleeding, the anastomosis could be performed with
directed additional saline flow; grade 4, profuse bleeding
and the anastomosis could not be performedwith the use of
LeGoo gel.
RESULTS
The patients were an average age of 73 years (range,
35-90 years). The symptomatic PVD was acute leg isch-
emia in 4 patients, Fontaine stage IV in 8, Fontaine stage
III in 1, and Fontaine stage II in 1. Cardiovascular risk
factors and comorbidities are listed in Table I.
LeGoo was used to occlude 5 anterior tibial arteries, 4
peroneal arteries, 2 posterior tibial arteries, 1 superficial
femoral artery, 1 popliteal artery, and 1 tibioperoneal trunk.
The conduit vessel used was a great saphenous vein in six
patients and a Dacron prosthesis in eight.
The proximal occlusion of the target vessel was ob-
tained with a mean quantity of 0.25 mL of LeGoo (range,
0.1-0.5 mL). A standard clamp was not required for any of
these patients. Four patients did not need a proximal injec-
tion because there was no bleeding from the proximal side
(occluded arteries). When an injection was given, one
injection of LeGoo on the proximal side was sufficient in 8
of 10 cases. Two patients required a second injection of
Table I. Clinical data
Variable
Mean  SD (range)
No. (ratio) (N  14)
Demographics data
Age, years 73  13 (35-90)
Men/women 9/5 (1.8)
Cardiovascular risk factors
Smoking 5
Hypertension 10
Dyslipidemia 10
Diabetes 10
Body mass index 30 kg/m2 3
Comorbidities
COPD 0
Coronaropathy 0
Cerebrovascular disease 4
Renal diseasea 3
COPD, Chronic obstructive pulmonary disease; SD, standard deviation.
aAssessed at creatinine 200 mol/L.LeGoo. Distal occlusion of the vessel was obtained with a tean quantity of 0.28 mL (range, 0.0-0.8 mL). One
njection of LeGoo was sufficient to stop back-bleeding in
1 patients, 3 required a second injection of LeGoo, and a
hird distal injection was needed in 1 patient due to bleed-
ng from collateral branches.
The mean occlusion time was 13.4  3.3 minutes
range, 2-18minutes). The total quantity of LeGoo needed
er case was 0.6  0.3 mL (range, 0.3-1.3 mL). After
ompletion of the anastomoses, the LeGoo plug was dis-
olved with saline by direct injection into the arteries in 13
f 14 patients.
After the completion angiogram in the first of our cases,
Fogarty balloon was used to remove a residual plug in an
nterior tibial artery rather than waiting for the gel to
issolve naturally. In this case, saline had been injected
hrough the proximal end of the graft rather than directly
nto the gel, leading to a longer-than-expected dissolution
ime. Operative data are presented in Table II.
The quality of hemostasis was grade 1 in 10 patients,
rade 2 in 2, grade 3 in 1, and grade 4 in 1. Grafts were
atent in 12 of 14 patients (85.7%) at 30 days.
Two postoperative deaths occurred in patients who
ere operated on for acute ischemia. One patient died of
ultiple organ failure on day 12. This patient suffered from
olyvascular disease, with myocardial infarction and limb
schemia, and underwent concomitant revascularization of
oronary and leg arteries. The second patient needed a
econd intervention for thrombosis of a Dacron prosthesis
ypass on the peroneal artery6 and died on day 2 of low
ardiac output.
ISCUSSION
Ideally, clamping of calcified small-bore arteries should
rovide an atraumatic blood-free field at the site of the
rteriotomy, without hampering the surgeon. LeGoo gel
eems to have these qualities. This polymer, which was
nitially used as an excipient for various medicines, is a
ontoxic, nonthrombotic occlusive gel. LeGoo gel uses a
oncentration of 20% of fractionated poloxamer P407. This
oncentration falls progressively when the polymer is in
ontact with the blood both upstream and downstream,
hich explains why blood flow sometimes resumes prema-
urely before completion of the anastomosis, requiring the
njection of more gel. The gel can be dissolved rapidly by
njecting physiologic saline directly into the arteries.
At the beginning of our study, one instance of residual
cclusion occurred in a distal artery due to poor rinsing
hrough the Dacron bypass once the anastomosis had been
ompleted. After the completion angiogram, a Fogarty
atheter was used to remove the gel rather than waiting for
t to dissolve naturally. From this case onward, we system-
tically removed gel residues before completing the anas-
omosis by injecting cold saline solution directly into the
rteries. We recommend that a completion angiogram of
he anastomosis and the downstream vascular bed be per-
ormed systematically at the end of the procedure (Fig 2).
Several experimental studies have shown the efficacy of
he procedure and the absence of intimal lesions in pig
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certificate in 2007, two clinical studies showed the efficacy
and safety of LeGoo gel in human coronary artery surgery.
The study by Bouchot et al10 confirmed the efficacy of
LeGoo in 99 coronary anastomoses without extracorporeal
circulation in 50 patients. The study by Rastan et al12
showed similar results in minimally invasive coronary artery
surgery in 10 patients compared with 10 control patients.
Clamping is difficult, not only in calcified arteries but
also when target arteries have been stented. This was the
case for our patient 4, who had a stent in the midpopliteal
Table II. Data on bypasses: number and volume of LeGo
Pt Target vessel Vessel conduit
Proxim
Injections
(No.)
1 Peroneal artery GSV 1
2 Tibioperoneal trunk Dacron prosthesis 1
3 Anterior tibial artery Dacron prosthesis 2
4 Popliteal Dacron prosthesis 0
5 Anterior tibial artery Dacron prosthesis 1
6 Posterior tibial artery GSV 1
7 SFA Dacron prosthesis 2
8 Anterior tibial artery Dacron prosthesis 1
9 Peroneal artery Dacron prosthesis 1
10 Anterior tibial artery GSV 0
11 Posterior tibial artery GSV 1
12 Peroneal artery GSV 1
13 Peroneal artery GSV 1
14 Anterior tibial artery Dacron prosthesis 1
Mean
GSV, Great saphenous vein; SFA, superficial femoral artery.
Fig 2. Final control angiogram of the first case in our experience
shows the distal anastomosis and the downstream vascular bed at
the end of a bypass on tibioperoneal trunk.artery and who required a bypass from the femoral to thepper popliteal artery, with a downstream artery that could
ot be clamped.
Finally, the LeGoo gel could be of interest to create
rteriovenous fistulas for patients who require hemodialy-
is. The first results seem to be satisfactory and will be
eported in a future publication.
ONCLUSIONS
This feasibility study showed that LeGoo provides tem-
orary arterial occlusion by blocking blood flow in small-
ore arteries in the lower limbs. LeGoo allows safe and
traumatic anastomosis. The plug facilitates the creation of
he anastomoses by maintaining the cylindrical shape of the
essels and can be easily pierced with a surgical needle.
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